Have any thoughts about
Seagen Inc?
Write Note

Seagen Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seagen Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Seagen Inc
F:SGT
Additional Paid In Capital
$5.3B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
19%
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.9B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$7B
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.1B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$12.3B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
18%

See Also

What is Seagen Inc's Additional Paid In Capital?
Additional Paid In Capital
5.3B USD

Based on the financial report for Sep 30, 2023, Seagen Inc's Additional Paid In Capital amounts to 5.3B USD.

What is Seagen Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
19%

Over the last year, the Additional Paid In Capital growth was 10%. The average annual Additional Paid In Capital growth rates for Seagen Inc have been 17% over the past three years , 16% over the past five years , and 19% over the past ten years .

Back to Top